Answers are grounded in this paper and cite their sources.
Background. Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy that most commonly affects the pleural lining of the lungs. MPM has a strong association with asbestos being at least 80% of cases caused by exposure to its biopersistent fibers. Individuals with a chronic exposure to asbestos generally have a 20-40-year latency with no or few symptoms. Such has been the case in the Piedmont and Lombardy regions of Italy where industrial production of materials laden with asbestos, mainly cements, has created a large number of patients. The fibers from this production did not only pose a substantial risk to the workers breathing the fibers, but also to the relatives and the surrounding community. Since 1992, the use of asbestos has been illegal in Italy, but such a long latency means that our center in the university town of Pavia, which is quite close to two former asbestos factories, is currently receiving a large number of patients. Methods. Since 2017 in Pavia, a multidisciplinary team has been collecting data on over 100 patients with MPM, including presentation, pathology type and the diagnostic method used. In addition, imaging data has also been analyzed in 49 patients who underwent CT with contrast prior to treatment. In this study, we bring together the abundant epidemiologic, histologic, radiologic, and other patient data to compare it with similar studies and draw correlations with predictive and prognostic significance. The basic descriptive statistical analysis was conducted through the Excel “Data Analysis” addon package. Results. Overall, the median survival (OS) was of 13.7 months. It was statistically influenced by the detection of pleural effusion at baseline (p<0.0001) and by histology (survival was higher in epidermoid forms (p<0.0001), irrespective of TNM disease stage. Conclusions. Quite unexpectedly, no statistically significant association could be demonstrated between OS and TNM disease stage at diagnosis. This result confirms that the TNM staging system is probably not adequate to manage MPM alone. Multidisciplinary approach to MPM has allowed us to create robust databases that will help guide radiomic projects, treatment research and thus improved patient management
No takes yet. Share an insight, caveat, or question.
Abbott et al. (2020) studied this question.